Previous Article | Next Article 
Journal of Virology, April 1999, p. 3484-3490, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Infectious Pancreatic Necrosis Virus:
Identification of a VP3-Containing Ribonucleoprotein Core Structure
and Evidence for O-Linked Glycosylation of the Capsid
Protein VP2
Anna
Hjalmarsson,1
Eric
Carlemalm,2 and
Einar
Everitt1,*
Department of
Microbiology1 and Electron Microscopy
Unit,2 Lund University, Lund, Sweden
Received 11 September 1998/Accepted 28 December 1998
 |
ABSTRACT |
Virions of infectious pancreatic necrosis virus (IPNV) were
completely disintegrated upon dialysis against salt-free buffers. Direct visualization of such preparations by electron microscopy revealed 5.0- to 6.5-nm-thick entangled filaments. By using a specific
colloidal gold immunolabeling technique, these structures were shown to
contain the viral protein VP3. Isolation by sucrose gradient
centrifugation of the filaments, followed by serological analysis,
demonstrated that the entire VP3 content of the virion was recovered
together with the radiolabeled genomic material forming the unique
threadlike ribonucleoprotein complexes. In a sensitive blotting assay,
the outer capsid component of IPNV, i.e., the major structural protein
VP2, was shown to specifically bind lectins recognizing sugar moieties
of N-acetylgalactosamine, mannose, and fucose. Three
established metabolic inhibitors of N-linked glycosylation did not
prevent addition of sugar residues to virions, and enzymatic
deglycosylation of isolated virions using N-glycosidase
failed to remove sugar residues of VP2 recognized by lectins. However,
gentle alkaline
elimination clearly reduced the ability of lectins
to recognize VP2. These results suggest that the glycosylation of VP2
is of the O-linked type when IPNV is propagated in RTG-2 cells.
 |
TEXT |
Infectious pancreatic necrosis virus
(IPNV) is an agent of contagious fish disease causing high mortality
among salmonid eggs and fingerlings (46). As for all members
of the family Birnaviridae, the naked capsid encloses the
two segments of double-stranded RNA (10, 33). Segment B
(2.3 × 106 Da) encodes the RNA-dependent RNA
polymerase VP1 (94 kDa) (11). The larger segment (segment A,
2.5 × 106 Da) contains two open reading frames. The
short one encodes a 17-kDa polypeptide identified only in infected
cells and not in purified virions (25). The long open
reading frame encodes a 106-kDa polyprotein which is cotranslationally
cleaved by a viral protease that is contained within the polyprotein
(designated NS or VP4, 29 kDa) into pVP2 (62 kDa) and VP3 (31 kDa)
(12, 24, 29). pVP2 is further processed during virus
maturation into VP2 (54 kDa), which is the polypeptide constituting the
icosahedral capsid (9). The glycosylation of this protein is
still a matter of controversy. Estay et al. (16) were able
to show the existence of N-linked oligosaccharides present on VP2 of
virions propagated in CHSE-214 cells. On the contrary, Perez et al.
(37) could not detect any carbohydrates on the viral
proteins expressed in the same cell line. In this study, we have
propagated IPNV in RTG-2 cells, and we found it worthwhile to
investigate if any glycosylation of the virus occurs in this cell line,
since it is possible that different cell lines give rise to different
types of glycosylation, quantitatively and/or qualitatively (6,
23). Better knowledge of glycosylation is important for future
studies on the tropism of this virus.
The second major structural protein, VP3, is known to be absent in
empty capsids and is therefore referred to as an internal protein
(8), but no reports regarding its function and exact localization inside the virion of IPNV have been published. In this
investigation, we disrupted virions gently by incubation in a
low-ionic-strength buffer and studied the released components by
serological methods and electron microscopy (EM).
Analysis of disintegrated virions by EM.
Highly purified IPNV
(4), serotype VR-299 (14), was dialyzed for 2 days at room temperature against a low-ionic-strength buffer (5 mM
Tris-HCl [pH 8.1], 0.2 mM EDTA) in order to gently disintegrate the
virions. The result, as assessed by negative staining with 2% uranyl
acetate and visualization by EM, was total disintegration of the viral
capsids and quantitative and highly reproducible release of aggregated
filamentous structures (Fig. 1A).
Aggregation of the filaments prevented any measurement of strand length
or estimation of the number of aggregated segments. Upon higher
magnification, smaller entities covering the filaments were visible,
thereby creating components with a thickness of 5.0 to 6.5 nm (Fig.
1B). Their appearance indicated that the structures might correspond to
double-stranded RNA (2 nm) covered by repeated units of a nucleic
acid-binding protein. By using the present preparation technique, we
were not able to detect condensed complexes with a shape fitting an
empty capsid, and we could not observe icosahedral structures similar
to the tentative cores described by Dobos et al. (9).
However, it is quite possible that VP3-RNA cores under other conditions
may be released as more condensed and subvirion-like structures that
would fit into the cavities seen in some virus preparations
(9). The results of our investigation indicate that the core
structure of IPNV displays similarities to the established cores of
adenoviruses, where highly basic protein VII is closely and
quantitatively associated with the DNA and is believed to neutralize
the negative charges along the sugar-phosphate backbone of the entire
genome (38, 39). Such adenovirus cores, released from
virions, have been visualized by EM and reveal an appearance similar to
that of the ribonucleoprotein complexes released from disrupted IPNV
(34).

View larger version (124K):
[in this window]
[in a new window]
|
FIG. 1.
Subviral components of IPNV. Visualization by EM of
filamentous structures released from virions dialyzed against a
low-ionic-strength buffer (A) and an enlargement of a section of a
tentative ribonucleoprotein complex (B) are shown. The horizontal bars
indicate 100 (A) and 50 (B) nm. Subviral components labeled with
colloidal-gold-conjugated MAbs against VP3 (C) or VP2 (D) and stained
with 2% uranyl acetate before examination by EM are shown. Under the
present conditions, the specimens in panels C and D were stained
positively. Bars in panels C and D, 200 nm.
|
|
To identify the viral proteins of the released filaments, disintegrated
virions were adsorbed to carbon-coated copper grids
that were
subsequently placed face down for 10 min on top of 30-µl
droplets of
suspensions of mouse immunoglobulin G (IgG) monoclonal
antibodies
(MAbs) against VP3 or VP2 (both produced in this laboratory
[
15]; Fig.
2A, inset) or
total mouse IgG, all bound to protein
A colloidal gold (10 nm; Sigma
Chemical Co., St. Louis, Mo.),
and diluted in phosphate-buffered saline
(PBS) containing 1% bovine
serum albumin (BSA) and 0.02% sodium
azide. After being washed
three times in PBS, the specimens were
stained with 2% uranyl
acetate. With this preparation technique, using
1% BSA to quench
the grid and to avoid unspecific protein-protein
binding, uranyl
acetate functions as a positive stain of the specimen
(
3,
34).
The highly specific binding of MAbs against VP3 to
the filaments
strongly suggests that VP3 was a component of the
structures released
from disrupted virions (Fig.
1C). The aggregation
of these structures
into larger and more contracted complexes was most
likely due
to excessive amounts of unconjugated antibodies that were
still
present. Neither MAbs against VP2 (Fig.
1D) nor total mouse IgG
(data not shown) caused any labeling or aggregation of the filaments,
and consequently, these structures were almost undetectable in
the
quenching film of BSA covering the grid.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Rate zonal sedimentation of intact and disintegrated
virions. IPNV stored in TNE (A) and IPNV dialyzed against
low-ionic-strength buffer (B) were sedimented by sucrose gradient
centrifugation. The RNA was measured as trichloroacetic
acid-precipitable, [3H]uridine-labeled material, and
viral proteins VP2 and VP3 were identified by MAbs in an ELISA and
detected as A410. The specificities of the MAbs
are shown in an immunoblot (inset in panel A). IPNV-infected RTG-2
cells were run in lanes 1 and 2, and purified IPNV was run in lane 3. Proteins in lane 1 were displayed by a MAb against VP2 (14/2d, also
recognizing pVP2), those in lane 2 by a MAb against VP3 (1/2f-3), and
the proteins in lane 3 were revealed by an anti-IPNV specific serum.
Material of the fraction from the sucrose gradient sedimentation of
disintegrated virions containing the highest concentrations of VP3 and
RNA was observed by negative staining and EM (C). Bar, 50 nm.
|
|
Rate sedimentation analysis of disintegrated virions.
The
existence of RNA in the filamentous structures observed by EM was
investigated by rate zonal centrifugation of
[3H]uridine-labeled disintegrated and intact virions.
Runs were made in sucrose gradients consisting of 2 × 1.8 ml of
10 to 25% (wt/vol) sucrose in TNE buffer (10 mM Tris-HCl [pH 7.5],
100 mM NaCl, 1 mM EDTA) layered on top of 800-µl cushions of CsCl at 50% relative saturation and 20% (wt/vol) sucrose in TNE buffer. Samples of 150 to 300 µl were applied on top of the gradients, and
centrifugations were carried out at 23,000 rpm (49,500 × g) for 6 h in an SW50.1 rotor at 10°C. The tubes were
punctured, and fractions were collected dropwise from the bottom.
Screening for virus-specific proteins was done by enzyme-linked
immunosorbent assay (ELISA) using MAbs against VP2 and VP3.
Radiolabeled RNA was quantified as trichloroacetic acid-precipitable
material in a liquid scintillation spectrometer. Viral components
released from the purified virions upon disintegration in the
low-ionic-strength buffer were recovered in two major regions (Fig.
2B). The faster-migrating material consisted of the comigrating total
detectable VP3 and RNA contents of the virus, whereas the released VP2
quantitatively remained on top of the gradient in a nonsedimentable
form (Fig. 2B). In a parallel centrifugation, intact virions sedimented
onto the high-density cushion at the bottom of the tube (Fig. 2A). The
strong signal of the MAbs against VP3 is noteworthy, bearing in mind
the suggested inner location of this polypeptide. The recognition of
VP3 could be due to possible disruption of intact virions upon
attachment to the plastic surface of the ELISA plates. Another
possibility is that some part of VP3 is exposed on the surface of the
virion since MAbs against VP3 have been shown to contain neutralizing
capacity (44) and also to recognize VP3 on purified IPNV in
ELISAs, as well as in immunodot assays (5). Furthermore,
antibodies against VP3 from total anti-IPNV serum have been
demonstrated to adsorb to intact virions (36).
Material recovered from fractions of the rate sedimentation analysis of
disintegrated virions, containing cosedimenting VP3
and RNA, was
visualized by EM, which unequivocally demonstrated
the existence of
filaments. These filaments appeared to be less
aggregated and thinner
(3 to 4 nm) (Fig.
2C) than prior to the
rate zonal sedimentation (Fig.
1A). However, since no VP2 was
detectable in the condensed form of the
filaments by labeling
with antibody-gold conjugates, and also since VP3
was still quantitatively
associated with the radiolabeled RNA after
sucrose gradient centrifugation
of disrupted virions, it is most
plausible that the decrease in
thickness was simply due to relaxation
of the more condensed form
caused by the environment of the higher
ionic strength of the
sucrose
gradients.
Our results suggest that VP3 is intimately associated with the segments
of viral RNA. The diameter of the filaments, as observed
in freshly
disintegrated particles, implies that VP3 is in a low-molecular-weight
form attached to the entire RNA segments. VP3 displays a pI of
6.6, which is the highest value among the proteins of IPNV (
16),
and of the last 43 carboxy-terminal amino acid residues, 25% consist
of the basic amino acids arginine and lysine (
12), and it is
logical to believe that this part of the protein is associated
with the
viral genome. For infectious bursal disease virus, another
member of
the
Birnaviridae family with biophysical and biochemical
characteristics similar to those of IPNV, it has been proposed
that VP3
may be a constituent of the capsid with the highly basic
carboxy-terminal end associated with the RNA genome (
2,
21).
From our investigation, it is not possible to ascertain if VP3
is a
part of the capsid, and as mentioned above, VP3 is not a
constituent of
empty capsids of IPNV (
8). During the low-ionic-strength
dialysis of virions, the capsids were totally disintegrated and
no VP2
could be detected in the filaments with gold-labeled antibodies.
This
indicates that the binding of VP2 to VP3, if there is any,
is weaker
than the VP3-RNA association under the present
conditions.
Lectin-binding properties of IPNV polypeptides.
To detect any
carbohydrates present on the proteins of highly purified virions, we
used 14 different lectins (Table 1) in a
sensitive lectin-blotting assay. The possibility of contaminating proteins being copurified with virions was minimized by an additional step of purification in which virions were briefly treated with 0.3%
Tween 20 and reisolated by isodensity centrifugation. Subsequently, the
viral polypeptides were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (26) and
transferred to nitrocellulose membranes. To increase the sensitivity
and specificity of the assay, the membranes were blocked with 2%
polyvinylpyrrolidone (molecular weight, 44,000; BDH Laboratory
Supplies, Poole, England) in PBS-0.05% Tween 20 overnight at 4°C
(1). The membranes were mounted in a Mini-protean II
multiscreen device (Bio-Rad Laboratories, Richmond, Calif.) and
biotinylated lectins (Lectin Screening Kits I and III; Vector
Laboratories, Inc., Burlingame, Calif.) with a variety of sugar
specificities (Table 1) were added to the channels at a concentration
of 2 µg/ml in 2% polyvinylpyrrolidone-PBS-0.05% Tween 20. Lectins
recognizing any glycoprotein upon incubation for 2 h at 22°C
were detected by incubation of the carefully washed membranes with
avidin conjugated with alkaline phosphatase and developed by standard
procedures. None of the lectins was able to bind at the
30,000-Mr position corresponding to VP3, and
this protein can therefore be considered an internal negative control. At the 54,000-Mr position of VP2, several
lectins bound with different specificities (Fig.
3; Table 1), suggesting the existence of oligosaccharides on VP2. Although the binding capacity differed from
lectin to lectin, it was clear that lectins preferentially recognizing
N-acetylgalactosamine (GalNAc), e.g., Dolichos
biflorus agglutinin, jacalin, peanut agglutinin, soybean
agglutinin (SBA), and Vicia villosa agglutinin, bound
significantly stronger than lectins with their highest specificity
toward N-acetylglucosamine (GlcNAc), e.g., Bandeiraea
simplicifolia lectin, Datura stramonium lectin,
Lycopersicon esculentum lectin, Solanum tuberosum
lectin, and wheat germ agglutinin (WGA) (41; Vector
Laboratories). This is interesting because GalNAc is the most-studied
saccharide bound to the amino acid serine or threonine by O linkage and
GlcNAc is the most abundant sugar in the core of N-linked
oligosaccharides. Consequently, the binding pattern of the lectins
implies O-linked glycosylation of VP2. Erythrina cristagalli
lectin (ECL) is one of the lectins giving a strong signal at the
position of VP2, and although ECL has its highest binding activity
toward galactosyl (
-1,4)-linked N-acetylglucosamine, this
lectin requires a galactose constituent in all bindings, again
supporting the former general binding pattern (Vector Laboratories).
Other sugars indicated to be present on VP2 were fucose and mannose,
binding Ulex europaeus agglutinin (UEA) and concanavalin A
(ConA), respectively (Fig. 3; Table 1). In an earlier study, the
presence of mannose in IPNV replicated in CHSE-214 cells was detected
with the lectin ConA (16). Furthermore, radiolabeled mannose
is incorporated into the virus particles if added 7 h
postinfection (p.i.) (16). However, if labeled mannose is
added in the final stage of virus replication (at 16 h p.i.)
(27), no labeling is found in the virions (37).
This lack of labeling could be due to the fact that glycosylation of
proteins is a posttranslational modification carried out before the
final assembly of the virions. In a control experiment, we therefore
had [3H]mannose (20 µCi/ml, 28.0 Ci/mmol) present in
the culture medium from 1 h p.i. until harvest 70 h later.
Virus was isolated and purified upon the occurrence of a total
cytopathic effect on the cells, and the viral polypeptides were
separated by SDS-PAGE. Quantification of radioactivity upon
CuCl2 staining and alkaline hydrolysis of gel pieces
containing the polypeptide bands revealed that 92% of the
radioactivity was confined to the polypeptide of VP2 and 8% was in the
region of polypeptides VP3 and VP3a, thus clearly demonstrating the
presence of mannose residues associated with VP2 in virus propagated in
RTG-2 cells. Furthermore, the label distribution also showed that
mannose was not significantly metabolically degraded and reused in
protein synthesis, although the label was allowed to be present for an
excessive period of time.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 3.
Lectin blot of virion polypeptides. IPNV was purified by
an additional step of isodensity centrifugation after detergent
treatment. Upon SDS-PAGE of the recovered virus and transblotting of
the polypeptides to a nitrocellulose membrane, carbohydrates were
monitored with 14 different lectins. The total amount of virion
proteins subjected to SDS-PAGE was 67 ng per channel (42).
The specificities of the different lectins are explained in Table 1.
The positions of the viral proteins were detected with a polyclonal
serum against IPNV ( IPNV). For definitions of abbreviations, see the
text and Table 1, footnote a.
|
|
Metabolic inhibition of glycosylation.
The biosynthetic events
leading to virion glycosylation were investigated in the presence of
three selected drugs that inhibit identified steps during the process
of N-linked glycosylation. It would have been desirable to employ a
drug with a documented effect only on O-linked glycosylation in this
study, but no such drug is available. At 1 h p.i., the following
drugs were added to separate cell culture flasks: 5- and 10-µg/ml
tunicamycin (Sigma), a transferase inhibitor blocking the first step in
the dolichol pathway; 3 mM deoxymannojirimycin (Calbiochem-Novabiochem
Corp., La Jolla, Calif.), a mannose analogue inhibiting mannosidase; and 4 mM N-methyl-1-deoxynojirimycin (Sigma), an inhibitor
of
-glucosidase (13, 18, 40). Upon the occurrence of an
apparent cytopathic effect (3 days p.i.), the virus was purified by
NaCl-polyethylene glycol precipitation (10), and the total
yield was determined quantitatively as A260.
Equal amounts of virus were analyzed by SDS-PAGE and subsequent
transblotting of the polypeptides. For practical reasons, purification
by precipitation was selected since several and different virus pools
with low virus content were processed separately and at the same time.
The extent of glycosylation, revealed as lectin binding, was monitored
with the lectins SBA, ConA, and UEA, which recognize GalNAc, mannose, and fucose, respectively. These three sugars are found at different positions in common oligosaccharides. GalNAc is frequently found attached to the hydroxyl group of serine or threonine by O linkage, mannose is detected mostly in inner cores of N-linked oligosaccharides, and fucose is a terminal sugar (6, 31). Figure
4 shows that no quantitative differences
in the carbohydrate contents of VP2 newly synthesized in the presence
of any of the drugs could be detected by the selected lectins,
suggesting a non-N-linked mechanism of glycosylation. These results do
not agree with the results obtained by Estay et al. (16),
who found a decrease of VP2-linked carbohydrates in the presence of
tunicamycin at 2 µg/ml when it was added to CHSE-214 cells at 4 h p.i. In the present investigation, the highest concentration of
tunicamycin was 10 µg/ml, and even though this concentration was
shown to be toxic to the cells, reducing viability by 50% after
48 h of cell growth in the presence of the drug (data not shown)
and, accordingly, resulting in a decreased virus yield, the relative
amount of glycosylated VP2 was constant. The finding that the
replication of IPNV per se is insensitive to tunicamycin, which has
been reported by both Estay et al. (16) and Perez et al.
(37), supports this observation.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of inhibitors of glycosylation. Virus-infected
cells were treated with the following glycosylation inhibitors added at
1 h p.i.: 10-µg/ml tunicamycin (tun), 3 mM deoxymannojirimycin
(dMM), and 4 mM N-methyl-1-deoxynojirimycin (MdN). The two
controls were virus replicated in the absence of any drug (no drug) and
mock-infected cells treated in the same way as the infected cells,
without any drug (uninf.). The latter material was recovered from
positions in a CsCl gradient corresponding to the viral bands in
gradients separating virus-containing material. To each SDS-PAGE lane,
0.30 µg of purified virion polypeptides (42) was applied,
and three different lectins were selected for the detection of
lectin-binding proteins (SBA, UEA, and ConA, recognizing GalNAc,
fucose, and mannose, respectively). A polyclonal serum against IPNV was
used for detection of viral proteins.
|
|
The inhibitory effect of tunicamycin was verified by growing RTG-2
cells for 48 h in the presence of the drug and
[
3H]mannose. The level of mannose incorporation,
measured as specific
radioactivity in counts per minute per microgram
of protein, was
reduced to 82% when the commonly used concentration of
tunicamycin
(2 µg/ml) (
28,
30,
35) was added and to 0.8%
in the presence
of the excessive tunicamycin concentration of 10 µg/ml, thus demonstrating
the anticipated effect of the
drug.
Deglycosylation of VP2.
The enzyme N-glycosidase F
(Boehringer GmbH, Mannheim, Germany) cleaves all types of
asparagine-linked carbohydrates (43) and was used to further
analyze the lectin-binding properties of the virus. IPNV was purified
by an additional centrifugation step as described above and quantified
spectrophotometrically as described by Smith et al. (42) to
yield data on total protein content. The lyophilized virus was
reconstituted in phosphate buffer (0.1 M sodium phosphate [pH 7.2],
10 mM EDTA, 0.02% sodium azide) containing 0.5% SDS and 5%
2-mercaptoethanol. The calculated amount of IPNV protein in each sample
was 3 µg, and the concentration was 0.25 µg/µl. The samples were
denatured by boiling prior to reduction of the SDS concentration to
0.1% by adding additional phosphate buffer, and to further prevent
inactivation of the enzyme by SDS, octyl-glucoside was added to a
concentration of 1% (20). Finally, the samples were
incubated with N-glycosidase F (30 U/ml) overnight at
37°C. Evaluation of the enzymatic reactions by SDS-PAGE, followed by
lectin blotting, showed that even a high ratio of N-glycosidase F to virion proteins under extreme conditions
did not affect the assessed levels of VP2 glycosylation (Fig.
5). Faint bands of viral proteins
migrating faster than VP2 after being subjected to
N-glycosidase F treatment were unveiled with the anti-IPNV
serum. This indicated a low level of proteolytic degradation rather
than deglycosylation, since the increase in the rate of migration is
too large to simply mirror a loss of sugar residues. The enzyme itself
is glycosylated and is therefore visualized in the lectin blot as a
band corresponding to an Mr of 34,000. The
proper function of the enzyme was demonstrated by complete
deglycosylation of human transferrin regarding carbohydrates recognized
by SBA (Fig. 5). Transferrin possesses two N-linked complex
carbohydrate chains with an inner core of GlcNAc and mannose and outer
chains containing GlcNAc, galactose, and sialic acid (7).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 5.
Enzymatic deglycosylation of purified IPNV. Virions of
IPNV were treated with N-glycosidase F (+) or left untreated
( ). Transferrin treated in the same way was used as a control.
Separation of the polypeptides by SDS-PAGE was followed by
transblotting and detection with a polyclonal serum against IPNV
( IPNV) and SBA. VP2 and VP3 indicate the positions of the viral
polypeptides, whereas PNGase F indicates the position of
N-glycosidase F, which is also recognized by SBA.
|
|
The inability of
N-glycosidase F to remove the carbohydrates
from VP2 further strengthened the indication that the linkage
between
the carbohydrates and the polypeptide was of an O-linked
type. To show
this, an effort was made to find a suitable assay
for the exclusion of
O-linked carbohydrates. A commercially available
O-glycosidase,
O-glycopeptide
endo-
D-galactosyl-
N-acetyl-

-galactosamino
hydrolase (EC 3.2.1.97; Boehringer), recognizing the disaccharide
Gal

3GalNAc and the trisaccharide Fuc

2Gal

3GalNAc (
23,
45),
was applied, but even with excessive concentrations of the
enzyme
and after prolonged periods of incubation, the optimal
conditions
for this enzyme were not found (data not shown). We
therefore
selected a pure chemical deglycosylation assay utilizing the
sensitivity
of the linkage between glycans and serine or threonine
toward
alkaline

elimination (
23,
31). Conditions were
optimized,
and the lyophilized virus was subsequently reconstituted
with
5 mM NaOH and 1 M NaBH
4 and incubated for 20 h at
37°C in a toluene
atmosphere (
17). By using this mild
treatment, degradation of
the proteins was minimized. The reaction was
stopped by pH neutralization
with HCl and cooling of the samples at
4°C. The amount of carbohydrates
still present was revealed by lectin
blotting using IPNV incubated
with PBS as a control. Any protein
degradation or increase in
the migration rate as a consequence of the
treatment was detected
with anti-IPNV serum. As expected, the N-linked
carbohydrates
of transferrin used as a negative control were unaffected
by this
treatment, whereas the positive control, the fiber of human
adenovirus
type 2 (Ad2), was totally deglycosylated (Fig.
6). This virus
contains GlcNAc, which is
strongly recognized by WGA. However,
the linkage to the protein moiety
is not, as expected, of the
N-linked type but is established as a
so-called dynamic O linkage
(
19,
22).

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 6.
Detection of polypeptides and carbohydrates after
alkaline elimination. Lyophilized samples of IPNV, human Ad2, and
transferrin (transf.) were incubated at 37°C for 20 h in 5 mM
NaOH with 1 M NaBH4 (+) or in PBS ( ) as described in the
text. Analysis by SDS-13% PAGE was followed by transblotting and
detection with antiserum ( IPNV and fiber are antibodies against
the glycosylated 62-kDa fiber protein of Ad2) or with lectins (SBA and
WGA). The amount of IPNV polypeptides applied to each lane was 0.37 µg, and those of the controls Ad2 and transf. were 3.3 and 0.5 µg,
respectively.
|
|
Although the amount of VP2, as detected by anti-IPNV serum, was
constant upon

elimination, the carbohydrate content of VP2
was
clearly reduced (Fig.
6), indicating that the VP2 of virions
propagated
in RTG-2 cells possessed O-linked oligosaccharides.
Removal of the
established small quantity of GlcNAc residues of
the Ad2 fiber, three
to four molecules per fiber molecule (
32),
revealed a
minimal effect on the migration rate on SDS-13% PAGE.
Likewise, the
migration of VP2 was unaffected upon

elimination
(Fig.
6), also
suggesting small quantities of
carbohydrates.
It was not in the scope of this investigation to determine the exact
residue composition of the oligosaccharides; however,
the lectin assay
implies the presence of GalNAc, mannose, and
fucose. In recent years, a
large number of novel carbohydrate
structures, monosaccharide
constituents as well as new linkages
between carbohydrates and the
peptide backbones, have been discovered.
For N-linked carbohydrates,
the most abundant amino acid sequence
required is NXS/T, and IPNV has
four of these sequences in VP2
that theoretically could be suitable for
glycosylation (
8).
However, our results indicate that the
glycosylation of VP2 is
O linked when virions are propagated in RTG-2
cells, and for O-linked
carbohydrates, it is the linkage between GalNAc
and serine or
threonine that is best known, and any further amino acid
requirements
in a specific motif to establish this linkage are not
known.
 |
ACKNOWLEDGMENTS |
We are indebted to Blanka Boberg for expert technical assistance
and to Lars-Olof Hedén for careful reading of the manuscript.
This investigation was supported by the Swedish Natural Science
Research Council and the Crafoord Foundation, Lund.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Lund University, Sölvegatan 12, S-223 62 Lund,
Sweden. Phone: 46 46 222 86 24. Fax: 46 46 15 78 39. E-mail:
Einar.Everitt{at}mikrbiol.lu.se.
 |
REFERENCES |
| 1.
|
Bartles, J. R., and A. L. Hubbard.
1984.
125I-wheat germ agglutinin blotting: increased sensitivity with polyvinylpyrrolidone quenching and periodate oxidation/reductive phenylamination.
Anal. Biochem.
140:284-292[Medline].
|
| 2.
|
Böttcher, B.,
N. Kieselev,
V. Stel'Mashchuk,
N. Perevozchikova,
A. Borisov, and R. Crowther.
1997.
Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy.
J. Virol.
71:325-330[Abstract].
|
| 3.
|
Brown, D.,
M. Westphal,
B. Burlingham,
U. Winterhoff, and W. Doerfler.
1975.
Structure and composition of the adenovirus type 2 core.
J. Virol.
16:366-387[Abstract/Free Full Text].
|
| 4.
|
Carlsson, A.,
J. Kuznar,
M. Varga, and E. Everitt.
1994.
Purification of infectious pancreatic necrosis virus by anion exchange chromatography increases the specific infectivity.
J. Virol. Methods
47:27-36[Medline].
|
| 5.
|
Caswell-Reno, P.,
P. W. Reno, and B. L. Nicholson.
1986.
Monoclonal antibodies to infectious pancreatic necrosis virus: analysis of viral epitopes and comparison of different isolates.
J. Gen. Virol.
67:2193-2206[Abstract/Free Full Text].
|
| 6.
|
Datema, R.,
S. Olofsson, and P. A. Romero.
1987.
Inhibitors of protein glycosylation and glycoprotein processing in viral systems.
Pharmacol. Ther.
33:221-286[Medline].
|
| 7.
|
de Jong, G.,
J. P. van Dijk, and H. G. van Eijk.
1990.
The biology of transferrin.
Clin. Chim. Acta
190:1-46[Medline].
|
| 8.
|
Dobos, P.
1995.
The molecular biology of infectious pancreatic necrosis virus (IPNV).
Annu. Rev. Fish Dis.
5:25-54.
|
| 9.
|
Dobos, P.,
R. Hallett,
D. T. C. Kells,
O. Sorensen, and D. Rowe.
1977.
Biophysical studies of infectious pancreatic necrosis virus.
J. Virol.
22:150-159[Abstract/Free Full Text].
|
| 10.
|
Dobos, P.,
B. J. Hill,
R. Hallett,
D. T. C. Kells,
H. Becht, and D. Teninges.
1979.
Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes.
J. Virol.
32:593-605[Abstract/Free Full Text].
|
| 11.
|
Duncan, R.,
C. Mason,
E. Nagy,
J. Leong, and P. Dobos.
1991.
Sequence analysis of infectious pancreatic necrosis virus genome segment B and its encoded VP1 protein: a putative RNA-dependent RNA polymerase lacking the gly-asp-asp motif.
Virology
181:541-552[Medline].
|
| 12.
|
Duncan, R.,
E. Nagy,
P. J. Krell, and P. Dobos.
1987.
Synthesis of the infectious pancreatic necrosis virus polyprotein, detection of a virus-encoded protease, and fine structure mapping of genome segment A coding regions.
J. Virol.
61:3655-3664[Abstract/Free Full Text].
|
| 13.
|
Elbein, A. D.
1987.
Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains.
Annu. Rev. Biochem.
56:497-534[Medline].
|
| 14.
|
Espinoza, E.,
G. Farias,
M. Soler, and J. Kuznar.
1985.
Identity between infectious pancreatic necrosis virus VR-299 and a Chilean isolate.
Intervirology
24:58-60[Medline].
|
| 15.
|
Espinoza, J. C.,
E. Everitt,
J. Vargas,
M. Soler, and J. Kuznar.
1993.
Reactividad de dos anticuerpos monoclonales preparados contra el virus de la necrosis pancreatica infecciosa.
Acta Microbiol.
4:23-32.
|
| 16.
|
Estay, A.,
G. Farias,
M. Soler, and J. Kuznar.
1990.
Further analysis on the structural proteins of infectious pancreatic necrosis virus.
Virus Res.
15:85-95[Medline].
|
| 17.
|
Florman, H., and P. Wassarman.
1985.
O-linked oligosaccharides of mouse egg ZP3 account for its sperm receptor activity.
Cell
41:313-324[Medline].
|
| 18.
|
Fuhrmann, U.,
E. Bause,
G. Legler, and H. Ploegh.
1984.
Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides.
Nature
307:755-758[Medline].
|
| 19.
|
Hart, G. W.
1997.
Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins.
Annu. Rev. Biochem.
66:315-335[Medline].
|
| 20.
|
Haselbeck, A., and W. Hösel.
1988.
Studies on the effect of the incubation conditions, various detergents and protein concentration on the enzymatic activity of N-glycosidase F (glycopeptidase F) and endoglycosidase F.
Top. Biochem. (Boehringer Mannheim GmbH)
8:1-4.
|
| 21.
|
Hudson, P. J.,
N. M. McKern,
B. E. Power, and A. A. Azad.
1986.
Genomic structure of the large RNA segment of infectious bursal disease virus.
Nucleic Acids Res.
14:5001-5012[Abstract/Free Full Text].
|
| 22.
|
Ishibashi, M., and J. V. Maizel.
1974.
The polypeptides of adenovirus. VI. Early and late glycopolypeptides.
Virology
58:345-361[Medline].
|
| 23.
|
Lis, H., and N. Sharon.
1993.
Protein glycosylation. Structural and functional aspects.
Eur. J. Biochem.
218:1-27[Medline].
|
| 24.
|
MacDonald, R., and P. Dobos.
1981.
Identification of the proteins encoded by each segment of infectious pancreatic necrosis virus.
Virology
114:414-422[Medline].
|
| 25.
|
Magyar, G., and P. Dobos.
1994.
Evidence for the detection of the infectious pancreatic necrosis virus polyprotein and the 17-kDa polypeptide in infected cells and of the NS protease in purified virus.
Virology
204:580-589[Medline].
|
| 26.
|
Maizel, J. V.
1971.
Polyacrylamide gel electrophoresis of viral proteins, p. 179-246.
In
K. Maramorosch, and H. Koprowski (ed.), Methods of virology, vol. 5. Academic Press, Inc., New York, N.Y.
|
| 27.
|
Malsberger, R. G., and C. P. Cerini.
1965.
Multiplication of infectious pancreatic necrosis virus.
Ann. N. Y. Acad. Sci.
126:320-327[Medline].
|
| 28.
|
McDowell, W.,
P. A. Romero,
R. Datema, and R. T. Schwarz.
1987.
Glucose trimming and mannose trimming affect different phases of the maturation of Sindbis virus in infected BHK cells.
Virology
161:37-44[Medline].
|
| 29.
|
Mertens, P., and P. Dobos.
1982.
Messenger RNA of infectious pancreatic necrosis virus is polycistronic.
Nature
297:243-246[Medline].
|
| 30.
|
Mirazimi, A.,
C. von Bonsdorff, and L. Svensson.
1996.
Effect of brefeldin A on rotavirus assembly and oligosaccharide processing.
Virology
217:554-563[Medline].
|
| 31.
|
Montreuil, J.,
S. Bouquelet,
H. Debray,
B. Fournet,
G. Spik, and G. Strecker.
1986.
Glycoproteins, p. 143-204.
In
M. Chaplin, and J. Kennedy (ed.), Carbohydrate analysis: a practical approach. IRL Press, Oxford, England.
|
| 32.
|
Mullis, K.,
G. Haltiwanger,
G. Hart,
R. Marchase, and J. Engler.
1990.
Relative accessibility of N-acetylglucosamine in trimers of the adenovirus type 2 and 5 fiber proteins.
J. Virol.
64:5317-5323[Abstract/Free Full Text].
|
| 33.
|
Murphy, F. A.,
C. M. Fauquet,
D. H. L. Bishop,
S. A. Ghabrial,
A. W. Jarvis,
G. P. Martelli,
M. A. Mayo, and M. D. Summers.
1995.
Virus taxonomy. Sixth report of the International Committee on Taxonomy of Viruses.
Arch. Virol.
1995(Suppl. 10):240-244.
|
| 34.
|
Nermut, M. V.
1980.
The architecture of adenoviruses: recent views and problems.
Arch. Virol.
64:175-196[Medline].
|
| 35.
|
Olofsson, S.,
M. Milla,
C. Hirschberg,
E. de Clercq, and R. Datema.
1988.
Inhibition of terminal N- and O-glycosylation specific for herpesvirus-infected cells: mechanism of an inhibitor of sugar nucleotide transport across Golgi membranes.
Virology
166:440-450[Medline].
|
| 36.
|
Park, J., and J. Gajin.
1996.
Identification of VP3 as an important neutralising epitope from DRT strain, a Korean isolate of infectious pancreatic necrosis virus (IPNV).
Fish Shellfish Imm.
6:207-219.
|
| 37.
|
Perez, L.,
P. Chiou, and J. Leong.
1996.
The structural proteins of infectious pancreatic necrosis virus are not glycosylated.
J. Virol.
70:7247-7249[Abstract/Free Full Text].
|
| 38.
|
Prage, L., and U. Pettersson.
1971.
Structural proteins of adenoviruses. VII. Purification and properties of an arginine-rich core protein from adenovirus type 2 and type 3.
Virology
45:364-373[Medline].
|
| 39.
|
Prage, L.,
U. Pettersson,
S. Höglund,
K. Lonberg-Holm, and L. Philipson.
1970.
Structural proteins of adenovirus. IV. Sequential degradation of the adenovirus type 2 virion.
Virology
42:341-358[Medline].
|
| 40.
|
Romero, P. A.,
R. Datema, and R. T. Schwartz.
1983.
N-methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing and its effect on fowl plaque virus maturation.
Virology
130:238-242[Medline].
|
| 41.
|
Sharon, N., and H. Lis.
1989.
Lectins.
Chapman & Hall, London, England.
|
| 42.
|
Smith, R.,
H. Zweerink, and W. Joklik.
1969.
Polypeptide components of virions, top component and cores of reovirus type 3.
Virology
39:791-810[Medline].
|
| 43.
|
Tarentino, A.,
C. Gómez, and T. Plummer.
1985.
Deglycosylation of aspargine-linked glycans by peptide: N-glycosidase F.
Biochemistry
24:4665-4671[Medline].
|
| 44.
|
Tarrab, E.,
L. Berthiaume,
J. Heppell,
M. Arella, and J. Lecomte.
1993.
Antigenic characterization of serogroup `A' of infectious pancreatic necrosis virus with three panels of monoclonal antibodies.
J. Gen. Virol.
74:2025-2030[Abstract/Free Full Text].
|
| 45.
|
Umemoto, J.,
V. Bhavanandan, and E. Davidson.
1977.
Purification and properties of an endo- -N-acetyl-D-galactosaminidase from Diplococcus pneumoniae.
J. Biol. Chem.
252:8609-8614[Abstract/Free Full Text].
|
| 46.
|
Wolf, K.,
S. Snieszko,
C. Dunbar, and E. Pyle.
1960.
Virus nature of infectious pancreatic necrosis in trout.
Proc. Soc. Exp. Biol. Med.
104:105-108.
|
Journal of Virology, April 1999, p. 3484-3490, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Irigoyen, N., Garriga, D., Navarro, A., Verdaguer, N., Rodriguez, J. F., Caston, J. R.
(2009). Autoproteolytic Activity Derived from the Infectious Bursal Disease Virus Capsid Protein. J. Biol. Chem.
284: 8064-8072
[Abstract]
[Full Text]
-
Luque, D., Rivas, G., Alfonso, C., Carrascosa, J. L., Rodriguez, J. F., Caston, J. R.
(2009). Infectious bursal disease virus is an icosahedral polyploid dsRNA virus. Proc. Natl. Acad. Sci. USA
106: 2148-2152
[Abstract]
[Full Text]
-
Hon, C.-C., Lam, T. T.-Y., Yip, C.-W., Wong, R. T.-Y., Shi, M., Jiang, J., Zeng, F., Leung, F. C.-C.
(2008). Phylogenetic evidence for homologous recombination within the family Birnaviridae. J. Gen. Virol.
89: 3156-3164
[Abstract]
[Full Text]
-
Garriga, D., Navarro, A., Querol-Audi, J., Abaitua, F., Rodriguez, J. F., Verdaguer, N.
(2007). Activation mechanism of a noncanonical RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA
104: 20540-20545
[Abstract]
[Full Text]
-
Pedersen, T., Skjesol, A., Jorgensen, J. B.
(2007). VP3, a Structural Protein of Infectious Pancreatic Necrosis Virus, Interacts with RNA-Dependent RNA Polymerase VP1 and with Double-Stranded RNA. J. Virol.
81: 6652-6663
[Abstract]
[Full Text]
-
Song, H., Santi, N., Evensen, O., Vakharia, V. N.
(2005). Molecular Determinants of Infectious Pancreatic Necrosis Virus Virulence and Cell Culture Adaptation. J. Virol.
79: 10289-10299
[Abstract]
[Full Text]
-
Villanueva, R. A., Galaz, J. L., Valdes, J. A., Jashes, M. M., Sandino, A. M.
(2004). Genome Assembly and Particle Maturation of the Birnavirus Infectious Pancreatic Necrosis Virus. J. Virol.
78: 13829-13838
[Abstract]
[Full Text]